Infinx Expands AI-driven Solutions with Glidian Acquisition

Infinx has acquired Glidian to enhance its AI-driven revenue cycle management solutions, focusing on automating patient access and prior authorizations. This strategic move aims to increase efficiency in the laboratory market and streamline workflows, benefiting healthcare providers and patients with improved automation and accuracy.

In a strategic move to bolster its AI-driven revenue cycle management solutions, Infinx has announced the acquisition of Glidian, a leading provider in prior authorization automation.

The acquisition aims to enhance Infinx's patient access solutions by deepening its presence in the laboratory market. Both companies have a shared vision of improving healthcare access through automation. Infinx CEO Jaideep Tandon highlighted the synergy between Glidian's technology and Infinx's existing solutions, emphasizing the potential for greater value to healthcare providers and patients.

With their combined expertise, Infinx and Glidian now process around 700,000 patient access transactions monthly, promising enhanced automation and streamlined workflows. This partnership is poised to deliver a more efficient healthcare authorization process, benefiting healthcare organizations and ultimately, patient care.

(With inputs from agencies.)